Genizon Biosciences Acquires Assets from Global Genomics to Accelerate the Discovery of Disease-Causing Mutations and Targets
Montreal, Canada (ots/PRNewswire) - Genizon BioSciences, Inc., a Montreal-based gene and drug target discovery company, announced today it has acquired the majority of the assets and staff of Sweden-based Global Genomics AB. Through this transaction, Genizon has gained access to a novel sequencing technology, ...